The latest research on the Chinese University of Hong Kong found that for primitive virus strains and Omikon mutant strains, vaccination of resurgence or Koxing crown vaccine can stimulate immune T cell reactions, and can effectively reduce crown diseases effectivelyThe risk of serious illness and death caused by the virus.The study also found Memory T cells in different vaccinations of the two vaccines. Whenever the human body is infected, the T cells will be re -activated to help long -term protection.
Comprehensive Ming Pao and online media "Hong Kong 01" reported on Tuesday (June 27) that the CUHK Research Team recruited 659 participants from 3 vaccination centers in Hong Kong from March to August 2021.Follow -up research, that is, two doses of two doses Futai or Kexing, vaccination of homologous or heterogeneous reinforcements, no vaccination reinforcements, or infected with any type of coronary virus strain, and before and after vaccination vaccine, and before and after vaccination vaccineCollect blood samples in one month and extract their blood samples during the recovery of the patient.
The results show that although the two doses of two doses Futai or the Kochi vaccine failed to trigger the neutralized antibody against Omikon, they could cause a large T cell response and eliminate virus infection to eliminate virus infections.Cells, to reduce virus replication, prevent the worsening of the condition, and achieve prevention and death.
Studies have pointed out that a T cell reaction caused by two doses of two doses of two doses of people 60 or above is greater than two doses of Koxing.Weakened T cell reaction.Studies have also found that two vaccines have memorized T cells. When they are infected again, they will be re -activated. It is believed that it can effectively prevent serious diseases caused by crown diseases for a long time, such as severe respiratory systems such as pneumonia.
